Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000627605 | SCV000748605 | likely pathogenic | not provided | 2022-02-22 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense-mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV002529811 | SCV003017879 | uncertain significance | RFT1-congenital disorder of glycosylation | 2022-06-18 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 524109). This variant has not been reported in the literature in individuals affected with RFT1-related conditions. This variant is present in population databases (rs748350251, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Glu400Argfs*8) in the RFT1 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in RFT1 cause disease. |